B-
B-
b-Fast.ai
Rapid bacterial identification and antibiotic susceptibility testing in under 45 minutes.
About
b-Fast.ai has developed a novel and patented method for the rapid identification of bacterial pathogens and their susceptibility to antibiotics. Their technology aims to deliver results within 45 minutes, significantly reducing the time required for clinical decision-making in infectious disease treatment.
Competitors & alternatives (6)
b-Fast.ai alternatives Key facts
At-a-glance profile data
- Website
- b-fast.ai
- Headquarters
- Tel Aviv, Israel
- Founded
- 2022
- Total funding
- -
- Business model
- B2B
Add first review
Frequently asked
What is b-Fast.ai's current status?
b-Fast.ai's current operating status is: Inactive.